Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.

Allen SP, Hall B, Woof R, Francis L, Gatto N, Shaw AC, Myszczynska M, Hemingway J, Coldicott I, Willcock A, Job L, Hughes RM, Boschian C, Bayatti N, Heath PR, Bandmann O, Mortiboys H, Ferraiuolo L, Shaw PJ.

Brain. 2019 Dec 1;142(12):3771-3790. doi: 10.1093/brain/awz302.

2.

Restriction of mitochondrial calcium overload by mcu inactivation renders a neuroprotective effect in zebrafish models of Parkinson's disease.

Soman SK, Bazała M, Keatinge M, Bandmann O, Kuznicki J.

Biol Open. 2019 Oct 15;8(10). pii: bio044347. doi: 10.1242/bio.044347.

3.

The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.

Jabbari E, Woodside J, Tan MMX, Pavese N, Bandmann O, Ghosh BCP, Massey LA, Capps E, Warner TT, Lees AJ, Revesz T, Holton JL, Williams NM, Grosset DG, Morris HR.

Mov Disord. 2019 Sep;34(9):1307-1314. doi: 10.1002/mds.27786. Epub 2019 Jul 12.

4.

Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher's disease.

Watson L, Keatinge M, Gegg M, Bai Q, Sandulescu MC, Vardi A, Futerman AH, Schapira AHV, Burton EA, Bandmann O.

Neurobiol Dis. 2019 Jul;127:563-569. doi: 10.1016/j.nbd.2019.04.008. Epub 2019 Apr 11.

PMID:
30981829
5.

Reduced habit-driven errors in Parkinson's Disease.

Bannard C, Leriche M, Bandmann O, Brown CH, Ferracane E, Sánchez-Ferro Á, Obeso J, Redgrave P, Stafford T.

Sci Rep. 2019 Mar 4;9(1):3423. doi: 10.1038/s41598-019-39294-z.

6.

The effect of hyperglycemia on neurovascular coupling and cerebrovascular patterning in zebrafish.

Chhabria K, Plant K, Bandmann O, Wilkinson RN, Martin C, Kugler E, Armitage PA, Santoscoy PL, Cunliffe VT, Huisken J, McGown A, Ramesh T, Chico TJ, Howarth C.

J Cereb Blood Flow Metab. 2018 Nov 6:271678X18810615. doi: 10.1177/0271678X18810615. [Epub ahead of print]

PMID:
30398083
7.

TIGAR inclusion pathology is specific for Lewy body diseases.

López KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR.

Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.

8.

Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease.

Bell SM, Barnes K, Clemmens H, Al-Rafiah AR, Al-Ofi EA, Leech V, Bandmann O, Shaw PJ, Blackburn DJ, Ferraiuolo L, Mortiboys H.

J Mol Biol. 2018 Oct 19;430(21):3942-3953. doi: 10.1016/j.jmb.2018.08.019. Epub 2018 Aug 29.

9.

The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.

Schöndorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK, Di Napoli G, Panagiotakopoulou V, Nestel S, Keatinge M, Pruszak J, Bandmann O, Heimrich B, Gasser T, Whitworth AJ, Deleidi M.

Cell Rep. 2018 Jun 5;23(10):2976-2988. doi: 10.1016/j.celrep.2018.05.009.

10.

Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Williams U, Bandmann O, Walker R.

J Mov Disord. 2018 May;11(2):53-64. doi: 10.14802/jmd.17028. Epub 2018 May 30. Review.

11.

Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting.

Taylor JC, Romanowski C, Lorenz E, Lo C, Bandmann O, Fenner J.

EJNMMI Res. 2018 May 8;8(1):36. doi: 10.1186/s13550-018-0393-5.

12.

Porphyria: often discussed but too often missed.

O'Malley R, Rao G, Stein P, Bandmann O.

Pract Neurol. 2018 Oct;18(5):352-358. doi: 10.1136/practneurol-2017-001878. Epub 2018 Mar 14. Review.

PMID:
29540448
13.

Animal models of Wilson disease.

Reed E, Lutsenko S, Bandmann O.

J Neurochem. 2018 Aug;146(4):356-373. doi: 10.1111/jnc.14323. Epub 2018 Jun 26. Review.

14.

The subresolution DaTSCAN phantom: a cost-effective, flexible alternative to traditional phantom technology.

Taylor JC, Vennart N, Negus I, Holmes R, Bandmann O, Lo C, Fenner J.

Nucl Med Commun. 2018 Mar;39(3):268-275. doi: 10.1097/MNM.0000000000000801.

15.

Translational approaches to restoring mitochondrial function in Parkinson's disease.

Mortiboys H, Macdonald R, Payne T, Sassani M, Jenkins T, Bandmann O.

FEBS Lett. 2018 Mar;592(5):776-792. doi: 10.1002/1873-3468.12920. Epub 2017 Dec 17. Review.

16.

Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review.

Pezzoli S, Cagnin A, Bandmann O, Venneri A.

Brain Sci. 2017 Jul 15;7(7). pii: E84. doi: 10.3390/brainsci7070084. Review.

17.

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.

Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, Gornall A, Klein JC, Lo C, Dennis G, Bandmann O, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Hu MTM.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx071.

18.

Epidemiology and introduction to the clinical presentation of Wilson disease.

Lo C, Bandmann O.

Handb Clin Neurol. 2017;142:7-17. doi: 10.1016/B978-0-444-63625-6.00002-1. Review.

PMID:
28433111
19.

Inhibition of the mitochondrial calcium uniporter rescues dopaminergic neurons in pink1-/- zebrafish.

Soman S, Keatinge M, Moein M, Da Costa M, Mortiboys H, Skupin A, Sugunan S, Bazala M, Kuznicki J, Bandmann O.

Eur J Neurosci. 2017 Feb;45(4):528-535. doi: 10.1111/ejn.13473. Epub 2016 Dec 28.

20.

Genetics of multiple system atrophy: Back to square one?

Bandmann O, Chio A.

Neurology. 2016 Oct 11;87(15):1530-1531. Epub 2016 Sep 14. No abstract available.

PMID:
27629090
21.

Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes.

Yealland G, Battaglia G, Bandmann O, Mortiboys H.

Neurosci Lett. 2016 Sep 6;630:23-29. doi: 10.1016/j.neulet.2016.06.065. Epub 2016 Jul 10.

22.

Huntington disease: More common than you think?

Delatycki MB, Bandmann O.

Neurology. 2016 Jul 19;87(3):247-8. doi: 10.1212/WNL.0000000000002874. Epub 2016 Jun 22. No abstract available.

PMID:
27335111
23.

Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.

Keatinge M, Bui H, Menke A, Chen YC, Sokol AM, Bai Q, Ellett F, Da Costa M, Burke D, Gegg M, Trollope L, Payne T, McTighe A, Mortiboys H, de Jager S, Nuthall H, Kuo MS, Fleming A, Schapira AH, Renshaw SA, Highley JR, Chacinska A, Panula P, Burton EA, O'Neill MJ, Bandmann O.

Hum Mol Genet. 2015 Dec 1;24(23):6640-52. doi: 10.1093/hmg/ddv369. Epub 2015 Sep 16.

24.

UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo.

Mortiboys H, Furmston R, Bronstad G, Aasly J, Elliott C, Bandmann O.

Neurology. 2015 Sep 8;85(10):846-52. doi: 10.1212/WNL.0000000000001905. Epub 2015 Aug 7.

25.

Wilson's disease and other neurological copper disorders.

Bandmann O, Weiss KH, Kaler SG.

Lancet Neurol. 2015 Jan;14(1):103-13. doi: 10.1016/S1474-4422(14)70190-5. Review.

26.

pH-sensitive tubular polymersomes: formation and applications in cellular delivery.

Robertson JD, Yealland G, Avila-Olias M, Chierico L, Bandmann O, Renshaw SA, Battaglia G.

ACS Nano. 2014 May 27;8(5):4650-61. doi: 10.1021/nn5004088. Epub 2014 Apr 29.

PMID:
24724711
27.

The documentation of consent and disclosure of neurogenetic testing outside clinical genetics.

Lo C, Martindale J, Hadjivassiliou M, Martin P, Dalton A, Bandmann O.

Neurogenetics. 2014 Mar;15(1):19-21. doi: 10.1007/s10048-014-0391-3. Epub 2014 Feb 11.

PMID:
24515844
28.

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration.

Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ.

Front Cell Neurosci. 2013 Oct 10;7:178. doi: 10.3389/fncel.2013.00178. Review.

29.

TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency.

Flinn LJ, Keatinge M, Bretaud S, Mortiboys H, Matsui H, De Felice E, Woodroof HI, Brown L, McTighe A, Soellner R, Allen CE, Heath PR, Milo M, Muqit MM, Reichert AS, Köster RW, Ingham PW, Bandmann O.

Ann Neurol. 2013 Dec;74(6):837-47. doi: 10.1002/ana.23999.

30.

Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease.

Mortiboys H, Aasly J, Bandmann O.

Brain. 2013 Oct;136(Pt 10):3038-50. doi: 10.1093/brain/awt224. Epub 2013 Sep 2.

PMID:
24000005
31.

C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study.

Cooper-Knock J, Frolov A, Highley JR, Charlesworth G, Kirby J, Milano A, Hartley J, Ince PG, McDermott CJ, Lashley T, Revesz T, Shaw PJ, Wood NW, Bandmann O.

Neurology. 2013 Aug 27;81(9):808-11. doi: 10.1212/WNL.0b013e3182a2cc38. Epub 2013 Jul 24.

32.

The common PARK8 mutation LRRK2G²⁰¹⁹S is not a risk factor for breast cancer in the absence of Parkinson's disease.

Mortiboys H, Cox A, Brock IW, Bandmann O.

J Neurol. 2013 Aug;260(8):2177-8. doi: 10.1007/s00415-013-7027-7. Epub 2013 Jul 4. No abstract available.

PMID:
23824357
33.

Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.

Hadjivassiliou M, Aeschlimann P, Sanders DS, Mäki M, Kaukinen K, Grünewald RA, Bandmann O, Woodroofe N, Haddock G, Aeschlimann DP.

Neurology. 2013 May 7;80(19):1740-5. doi: 10.1212/WNL.0b013e3182919070. Epub 2013 Apr 10.

PMID:
23576621
34.

A genetic study of Wilson's disease in the United Kingdom.

Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O.

Brain. 2013 May;136(Pt 5):1476-87. doi: 10.1093/brain/awt035. Epub 2013 Mar 21.

35.

Delayed toxic-hypoxic encephalopathy.

Blackburn DJ, Alix JJ, Sarrigiannis P, Hoggard N, Bandmann O.

Pract Neurol. 2013 Apr;13(2):114-9. doi: 10.1136/practneurol-2012-000402. No abstract available.

PMID:
23468562
36.

Biomarkers for PD: How can we approach complexity?

Berg D, Bandmann O.

Neurology. 2013 Feb 12;80(7):608-9. doi: 10.1212/WNL.0b013e3182825184. Epub 2013 Jan 16. No abstract available.

PMID:
23325899
37.

Heterozygous mutations in the FGF8, SHH and nodal/transforming growth factor beta pathways do not confer increased dopaminergic neuron vulnerability--a zebrafish study.

Lo C, Flinn LJ, Bandmann O.

Neurosci Lett. 2013 Jan 4;532:55-8. doi: 10.1016/j.neulet.2012.10.035. Epub 2012 Nov 2.

PMID:
23123778
38.

The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Quarrell O, O'Donovan KL, Bandmann O, Strong M.

PLoS Curr. 2012 Jul 20;4:e4f8606b742ef3. doi: 10.1371/4f8606b742ef3.

39.

Prolonged generalized dystonia after chronic cerebellar application of kainic acid.

Alvarez-Fischer D, Grundmann M, Lu L, Samans B, Fritsch B, Möller JC, Schaefer MK, Hartmann A, Oertel WH, Bandmann O.

Brain Res. 2012 Jun 29;1464:82-8. doi: 10.1016/j.brainres.2012.05.007. Epub 2012 May 15.

PMID:
22595488
40.

Parkinson disease, cancer, and LRRK2: causation or association?

Bandmann O, Cookson MR.

Neurology. 2012 Mar 13;78(11):772-3. doi: 10.1212/WNL.0b013e318249f744. Epub 2012 Feb 8. No abstract available.

PMID:
22323745
41.

The influence of the zebrafish genetic background on Parkinson's disease-related aspects.

Bretaud S, MacRaild S, Ingham PW, Bandmann O.

Zebrafish. 2011 Sep;8(3):103-8. doi: 10.1089/zeb.2011.0697. Epub 2011 Jul 11.

PMID:
21745139
42.

Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.

Mortiboys H, Johansen KK, Aasly JO, Bandmann O.

Neurology. 2010 Nov 30;75(22):2017-20. doi: 10.1212/WNL.0b013e3181ff9685.

PMID:
21115957
43.

Genetic zebrafish models of neurodegenerative diseases.

Bandmann O, Burton EA.

Neurobiol Dis. 2010 Oct;40(1):58-65. doi: 10.1016/j.nbd.2010.05.017. Epub 2010 May 20. Review.

PMID:
20493258
44.

Parkinson's disease: insights from pathways.

Cookson MR, Bandmann O.

Hum Mol Genet. 2010 Apr 15;19(R1):R21-7. doi: 10.1093/hmg/ddq167. Epub 2010 Apr 26. Review.

45.

Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Wignall EL, Griffiths PD, Papadakis NG, Wilkinson ID, Wallis LI, Bandmann O, Cowell PE, Hoggard N.

AJNR Am J Neuroradiol. 2010 May;31(5):856-61. doi: 10.3174/ajnr.A2005. Epub 2010 Mar 18.

46.

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.

Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ.

Nat Neurosci. 2009 Sep;12(9):1129-35. doi: 10.1038/nn.2372. Epub 2009 Aug 16.

47.

Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio).

Flinn L, Mortiboys H, Volkmann K, Köster RW, Ingham PW, Bandmann O.

Brain. 2009 Jun;132(Pt 6):1613-23. doi: 10.1093/brain/awp108. Epub 2009 May 12.

PMID:
19439422
48.

Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts.

Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O.

Ann Neurol. 2008 Nov;64(5):555-65. doi: 10.1002/ana.21492.

49.

Yet another spinocerebellar ataxia: the saga continues.

Bandmann O, Singleton AB.

Neurology. 2008 Aug 19;71(8):542-3. doi: 10.1212/01.wnl.0000323932.90720.55. No abstract available.

PMID:
18711106
50.

Immunophenotyping in Tourette syndrome--a pilot study.

Möller JC, Tackenberg B, Heinzel-Gutenbrunner M, Burmester R, Oertel WH, Bandmann O, Müller-Vahl KR.

Eur J Neurol. 2008 Jul;15(7):749-53. doi: 10.1111/j.1468-1331.2008.02159.x. Epub 2008 May 15.

PMID:
18484991

Supplemental Content

Loading ...
Support Center